Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2020-11-10 Purchase |
2020-11-10 2:45 pm |
GENOCEA BIOSCIENCES INC. | GNCA | Clark William D President and CEO |
4,760 | $2.06 | $9,806 | 4,760 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2021-07-01 Option Award |
2021-07-02 11:59 am |
2022-07-01 2031-07-01 |
GENOCEA BIOSCIENCES INC. | GNCA | Schwab Gisela Director |
15,000 | $0 | 15,000 (Direct) |
View |
| 2021-07-01 Option Award |
2021-07-02 11:56 am |
2022-07-01 2031-07-01 |
GENOCEA BIOSCIENCES INC. | GNCA | Siber George Director |
15,000 | $0 | 15,000 (Direct) |
View |
| 2021-07-01 Option Award |
2021-07-02 11:54 am |
2022-07-01 2031-07-01 |
GENOCEA BIOSCIENCES INC. | GNCA | BATE KENNETH Director |
15,000 | $0 | 15,000 (Direct) |
View |
| 2021-07-01 Option Award |
2021-07-02 11:50 am |
2022-07-01 2031-07-01 |
GENOCEA BIOSCIENCES INC. | GNCA | Bosley Katrine Director |
15,000 | $0 | 15,000 (Direct) |
View |
| 2021-07-01 Option Award |
2021-07-02 11:49 am |
2022-07-01 2031-07-01 |
GENOCEA BIOSCIENCES INC. | GNCA | Higgins Michael J Director |
15,000 | $0 | 15,000 (Direct) |
View |
| 2021-03-15 Option Award |
2021-03-17 1:59 pm |
N/A 2031-03-15 |
GENOCEA BIOSCIENCES INC. | GNCA | Duvall Diantha CHIEF FINANCIAL OFFICER |
250,000 | $0 | 250,000 (Direct) |
View |
| 2021-03-15 Option Award |
2021-03-17 1:56 pm |
N/A 2031-03-15 |
GENOCEA BIOSCIENCES INC. | GNCA | Clark William D President and CEO |
1,200,000 | $0 | 1,200,000 (Direct) |
View |
| 2021-03-15 Option Award |
2021-03-17 1:55 pm |
N/A 2031-03-15 |
GENOCEA BIOSCIENCES INC. | GNCA | Flechtner Jessica Baker Chief Scientific Officer |
275,000 | $0 | 275,000 (Direct) |
View |
| 2021-03-15 Option Award |
2021-03-17 1:53 pm |
N/A 2031-03-15 |
GENOCEA BIOSCIENCES INC. | GNCA | Aakalu Girish N CHIEF BUSINESS OFFICER |
225,000 | $0 | 225,000 (Direct) |
View |
| 2021-03-15 Option Award |
2021-03-17 1:50 pm |
N/A 2031-03-15 |
GENOCEA BIOSCIENCES INC. | GNCA | Davis Thomas Andrew CHIEF MEDICAL OFFICER |
225,000 | $0 | 225,000 (Direct) |
View |
| 2021-03-15 Option Award |
2021-03-17 1:48 pm |
N/A N/A |
GENOCEA BIOSCIENCES INC. | GNCA | SUMER JACQUELYN L CHIEF LEGAL & COMPLIANCE OFF |
100,000 | $0 | 100,000 (Direct) |
View |
| 2021-03-15 Option Award |
2021-03-17 1:46 pm |
N/A N/A |
GENOCEA BIOSCIENCES INC. | GNCA | STAPLETON RAYMOND D JR EVP PHARM SCI & MFG |
100,000 | $0 | 100,000 (Direct) |
View |
| 2021-03-01 Option Award |
2021-03-02 09:11 am |
N/A 2031-03-01 |
GENOCEA BIOSCIENCES INC. | GNCA | SUMER JACQUELYN L CHIEF LEGAL & COMPLIANCE OFF |
115,000 | $3.07 | 115,000 (Direct) |
View |
Ownership |
2021-02-23 1:45 pm |
N/A N/A |
GENOCEA BIOSCIENCES INC. | GNCA | SUMER JACQUELYN L CHIEF LEGAL & COMPLIANCE OFF |
0 | $0 | 5,500 (Direct) |
View |
| 2021-02-17 Exercise |
2021-02-18 11:25 am |
N/A 2030-06-01 |
GENOCEA BIOSCIENCES INC. | GNCA | Clark William D President and CEO |
36,498 | $0 | 321,440 (Direct) |
View |
| 2021-02-17 Exercise |
2021-02-18 11:25 am |
N/A N/A |
GENOCEA BIOSCIENCES INC. | GNCA | Clark William D President and CEO |
19,998 | $2.72 | 321,440 (Direct) |
View |
| 2021-02-17 Exercise |
2021-02-18 11:25 am |
N/A N/A |
GENOCEA BIOSCIENCES INC. | GNCA | Clark William D President and CEO |
16,500 | $1.66 | 321,440 (Direct) |
View |
| 2021-02-01 Option Award |
2021-02-01 5:09 pm |
N/A 2031-02-01 |
GENOCEA BIOSCIENCES INC. | GNCA | STAPLETON RAYMOND D JR EVP PHARM SCI & MFG |
125,000 | $0 | 125,000 (Direct) |
View |